Chime Biologics Celebrates 10-Year Anniversary – New Journey, Go Beyond
Article Date
June 9, 2023
This article is featured on another website.
Go to article
September 6, 2023
MD Anderson and Panacea launch Manaolana Oncology to develop antibody-based therapies for cancer
The University of Texas MD Anderson Cancer Center and Panacea Venture today announced the launch of Manaolana Oncology Inc., a new company created to develop and advance antibody-based therapies against novel cancer antigens.
September 6, 2023
MD Anderson and Panacea launch Manaolana Oncology to develop antibody-based therapies for cancer
The University of Texas MD Anderson Cancer Center and Panacea Venture today announced the launch of Manaolana Oncology Inc., a new company created to develop and advance antibody-based therapies against novel cancer antigens.